STDFX
Price
$41.90
Change
+$0.46 (+1.11%)
Updated
Dec 20 closing price
VIGIX
Price
$216.58
Change
+$1.76 (+0.82%)
Updated
Dec 23 closing price
Ad is loading...

STDFX vs VIGIX

Header iconSTDFX vs VIGIX Comparison
Open Charts STDFX vs VIGIXBanner chart's image
Allspring Large Cap Growth Admin
Price$41.90
Change+$0.46 (+1.11%)
VolumeN/A
CapitalizationN/A
Vanguard Growth Index Institutional
Price$216.58
Change+$1.76 (+0.82%)
VolumeN/A
CapitalizationN/A
STDFX vs VIGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
STDFX vs. VIGIX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STDFX is a StrongBuy and VIGIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 282B vs. STDFX (969M). VIGIX pays higher dividends than STDFX: VIGIX (0.53) vs STDFX (0.00). STDFX was incepted earlier than VIGIX: STDFX (14 years) vs VIGIX (27 years). STDFX is a more actively managed with annual turnover of: 51.00 vs. VIGIX (5.00). STDFX has a lower initial minimum investment than VIGIX: STDFX (1000000) vs VIGIX (5000000). VIGIX annual gain was more profitable for investors over the last year : 34.37 vs. STDFX (15.55). VIGIX return over 5 years is better than : 129.76 vs. STDFX (-2.74).
STDFXVIGIXSTDFX / VIGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years27 years-
Gain YTD15.23734.27244%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets969M282B0%
Annual Yield % from dividends0.000.53-
Returns for 1 year15.5534.3745%
Returns for 3 years-14.9232.77-46%
Returns for 5 years-2.74129.76-2%
Returns for 10 years-10.60298.58-4%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCL238.437.67
+3.32%
Royal Caribbean Group
ATUS2.640.08
+3.13%
Altice USA
CCCC3.950.11
+2.73%
C4 Therapeutics
PFSI101.661.56
+1.56%
PennyMac Financial Services
ELEV0.58-0.05
-7.30%
Elevation Oncology